PAIN MEDICINE, published by Oxford University Press, is a leading journal in the disciplines of Anesthesiology and Pain Medicine. With its ISSN 1526-2375 and E-ISSN 1526-4637, this esteemed journal provides a platform for innovative research and clinical advancements in the field of pain management. With an impressive impact factor attributed to its Q1 ranking in both Anesthesiology and Pain Medicine as well as Q2 in Clinical Neurology for 2023, PAIN MEDICINE ensures high visibility and relevance within the scientific community, noted for its diverse contributions from across the globe. The journal's editorial mission focuses on disseminating significant findings that influence contemporary practices and policies in pain management. Scholars and practitioners are encouraged to engage with this vital resource, which shapes the future of pain medicine from its base at Great Clarendon St, Oxford, England, covering a remarkable timeline from 2000 to 2024.

Agri - The Journal of the Turkish Society of Algology, published by KARE PUBL, is a significant academic platform dedicated to advancing the field of anesthesiology and pain medicine. Established in 1993, this journal has made substantial contributions towards understanding pain management strategies and therapeutic interventions in the medical community in Turkey and beyond. With an impact factor reflecting its Q3 category ranking within Anesthesiology and Pain Medicine and a respectable Scopus rank of 93 out of 136, it provides critical insights and research findings that are instrumental for both clinicians and researchers alike. The journal operates under an open access model, which enhances the visibility and accessibility of valuable research outputs for a global audience. An essential resource for professionals in pain management, Agri encourages the exchange of innovative ideas and groundbreaking studies within this vital area of medicine.

Frontiers in Pain Research is a leading open-access journal published by FRONTIERS MEDIA SA in Switzerland, devoted exclusively to advancing our understanding of pain, its mechanisms, and management. With an E-ISSN of 2673-561X and a strong dedication to academic rigor, the journal has quickly gained recognition in the field, boasting significant standings in various categories: Q2 in Anesthesiology and Pain Medicine and Q1 in Health Professions (miscellaneous) as of 2023. This interdisciplinary journal aims to facilitate the dissemination of novel research findings and therapeutic insights, contributing to enhanced patient care and improved outcomes. It holds credible ranks such as 20th percentile in Health Professions and 66th in Anesthesiology, solidifying its role as a vital resource for researchers, healthcare professionals, and students. The journal is committed to providing unrestricted access to its published works to spark global collaboration and dialogue in the crucial area of pain research.

Anaesthesia Critical Care & Pain Medicine is a leading academic journal published by Elsevier France - Editions Scientifiques Medicales Elsevier, known for its commitment to advancing knowledge in the fields of Anesthesiology, Critical Care, and Pain Medicine. With an impressive impact factor reflected by its Q1 rankings in pivotal categories such as Anesthesiology and Pain Medicine, and Critical Care and Intensive Care Medicine, this journal stands out for its rigorous peer-reviewed articles and innovative research contributions. Established in 2015, it provides a critical platform for international scholars and practitioners to disseminate their findings and engage with contemporary challenges in acute and pain management, ultimately improving patient care globally. With open access options available, the journal ensures that its significant research is accessible to a broader audience, encouraging collaboration and knowledge sharing within this vital field of medicine. For those at the forefront of medical practice, Anaesthesia Critical Care & Pain Medicine serves as an invaluable resource for ongoing education and professional development.

Pain Research & Management, published by HINDAWI LTD, is a leading academic journal that serves as a vital resource for researchers, clinicians, and students in the fields of anesthesiology, pain medicine, and neurology. With an impressive impact factor and categorized in the second quartile (Q2) for both anesthesiology and neurology as of 2023, the journal features high-quality, peer-reviewed research articles that address the complexities of pain management. Established in 1996 and recognized as Open Access, this journal allows unrestricted access to groundbreaking studies, thereby facilitating knowledge dissemination and collaboration within the global scientific community. With a strong ranking—34/136 in anesthesiology and 72/192 in neurology—Pain Research & Management retains a well-deserved reputation for publishing innovative and authoritative content that significantly contributes to the advancement of pain research and clinical practice. Researchers and healthcare professionals alike will find this journal indispensable for staying abreast of the latest discoveries and best practices in pain management.

THERAPEUTISCHE UMSCHAU, published by HOGREFE AG in Switzerland, serves as a vital resource for researchers and professionals in the field of medicine. With an ISSN of 0040-5930 and E-ISSN 1664-2864, this journal has been a credible platform for scientific discourse since its inception in 1947. It is currently ranked in the Q4 category in Medicine (miscellaneous) and holds a position of #462 out of 636 in the Scopus rankings for General Medicine, placing it in the 27th percentile. Although it does not offer open access, the journal presents a wealth of articles that cover diverse therapeutic methods and advancements, catering to a broad audience from seasoned practitioners to emerging scholars. As it converges towards the year 2024, THERAPEUTISCHE UMSCHAU continues to emphasize the importance of innovative research in clinical efficacy and healthcare practices, reflecting its ongoing commitment to advancing medical knowledge and patient care.

Current Pain and Headache Reports, published by SPRINGER, is a leading journal in the dynamic fields of anesthesiology, pain medicine, and clinical neurology. Since its inception in 2001, this journal has played a pivotal role in disseminating high-quality, peer-reviewed research that addresses the complex challenges associated with pain and headache disorders. With an impressive 2023 impact factor placing it in the Q1 quartile for Anesthesiology and Pain Medicine, and notable rankings in Clinical Neurology, it is a crucial resource for researchers, clinicians, and students seeking to advance their knowledge and practice in these vital areas of medicine. The journal supports a broad spectrum of scholarly activities by publishing original research, reviews, and expert opinion pieces, contributing significantly to the ongoing dialogue in pain management and headache treatment. As a subscription-based journal based in the United States, Current Pain and Headache Reports ensures that all articles meet rigorous scientific standards, fostering innovation and collaboration across multiple disciplines.

SCHMERZ is a pivotal journal in the fields of anesthesiology, pain medicine, and clinical neurology, published by SPRINGER HEIDELBERG in Germany. With an ISSN of 0932-433X and an E-ISSN of 1432-2129, the journal is celebrated for its rigorous peer-reviewed articles contributing to the understanding and management of pain. Since its inception in 1987, SCHMERZ has developed an impressive readership, ranking in the Q3 category across multiple disciplines, including Anesthesiology and Pain Medicine, and Clinical Neurology. Operating within the 50th percentile for anesthesiology and the 32nd percentile in neurology, the journal stands as a critical resource for practitioners, researchers, and students engaging with current trends and advancements in pain research and treatment. While not currently offering open access options, SCHMERZ continues to strive toward disseminating high-quality research and fostering vital discussions in the management of pain. With a scope that aims to bridge clinical practices with scientific understanding, SCHMERZ invites contributions that will illuminate and advance the multifaceted nature of pain and its treatment.

Pain and Therapy is a prestigious, peer-reviewed journal published by SPRINGER INTERNATIONAL PUBLISHING AG that has been a beacon of research in the field of pain management and neurology since its inception in 2012. With an ISSN of 2193-8237 and an E-ISSN of 2193-651X, this open access journal facilitates the dissemination of high-quality research to a global audience. Recognized within the top Q1 quartile for Anesthesiology and Pain Medicine, and the Q2 category for Clinical Neurology, it ranks impressively within the Scopus indexing, positioned at #20/136 in its primary category, demonstrating an 85th percentile standing. The journal's commitment to open access enhances its impact, allowing researchers, clinicians, and students to explore and contribute to critical developments in pain therapy and management. The convergence of cutting-edge research and innovative therapeutic strategies makes Pain and Therapy an essential resource for anyone dedicated to advancing knowledge in this vital field.

Journal of Endometriosis and Pelvic Pain Disorders, published by SAGE Publications Ltd, is a vital resource dedicated to advancing the understanding and management of endometriosis and associated pelvic pain disorders. With an ISSN of 2284-0265 and E-ISSN 2284-0273, this journal caters to a diverse audience of researchers, healthcare professionals, and students in the field of Obstetrics and Gynecology. It has a notable 2023 Scopus ranking of #139 out of 209 in its category, positioning it within the Q3 quartile based on its impact and contribution to the literature. The journal aims to publish cutting-edge research, reviews, and clinical guidelines that illuminate the complexities of endometriosis and enhance patient care. Available through various academic channels, it not only fosters scholarly discourse but also supports the academic community in addressing the challenges and advancements in the treatment of pelvic pain disorders. As the journal approaches its converged years from 2013 to 2024, it stands as a critical platform for disseminating impactful findings in a field that significantly affects women’s health globally.